Avricore Health Inc. (AVCRF)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 20.67 Thousand CAD | 8880274381209500.0% |
| 2022 | - CAD | 0.0% |
| 2021 | - CAD | -100.0% |
| 2020 | 1.00 CAD | 0.0% |
| 2019 | - CAD | -100.0% |
| 2018 | 102.49 Thousand CAD | -51.47% |
| 2017 | 211.22 Thousand CAD | -80.0% |
| 2016 | 1.05 Million CAD | 196.47% |
| 2015 | 356.28 Thousand CAD | 0.0% |
| 2014 | 356.28 Thousand CAD | 2233.34% |
| 2013 | -16.7 Thousand CAD | -283.99% |
| 2012 | 9077.00 CAD | -90.44% |
| 2011 | 94.92 Thousand CAD | -84.01% |
| 2010 | 593.57 Thousand CAD | 859.95% |
| 2009 | 61.83 Thousand CAD | 492.11% |
| 2008 | 10.44 Thousand CAD | -47.56% |
| 2007 | 19.91 Thousand CAD | -36.33% |
| 2006 | 31.28 Thousand CAD | -28.37% |
| 2005 | 43.66 Thousand CAD | -69.87% |
| 2004 | 144.91 Thousand CAD | 0.0% |
| 2003 | - CAD | 0.0% |
| 2002 | - CAD | 0.0% |
| 2001 | - CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 9045.00 CAD | 0.0% |
| 2024 Q1 | 9045.00 CAD | -56.25% |
| 2023 Q2 | - CAD | -100.0% |
| 2023 FY | 20.67 Thousand CAD | 8880274381209500.0% |
| 2023 Q4 | 20.67 Thousand CAD | 0.0% |
| 2023 Q3 | - CAD | 0.0% |
| 2023 Q1 | 1.00 CAD | 429496729500.0% |
| 2022 Q2 | - CAD | 0.0% |
| 2022 FY | - CAD | 0.0% |
| 2022 Q4 | - CAD | -100.0% |
| 2022 Q3 | 1.00 CAD | 0.0% |
| 2022 Q1 | - CAD | 0.0% |
| 2021 Q2 | - CAD | -100.0% |
| 2021 Q1 | 1.00 CAD | 0.0% |
| 2021 Q3 | - CAD | 0.0% |
| 2021 FY | - CAD | -100.0% |
| 2021 Q4 | - CAD | 0.0% |
| 2020 Q1 | 1.00 CAD | 0.0% |
| 2020 Q2 | 1.00 CAD | 0.0% |
| 2020 FY | 1.00 CAD | 0.0% |
| 2020 Q3 | 176.86 Thousand CAD | 17686400.0% |
| 2020 Q4 | 1.00 CAD | -100.0% |
| 2019 Q1 | 108.79 Thousand CAD | 6.14% |
| 2019 Q2 | 3226.00 CAD | -97.03% |
| 2019 Q3 | - CAD | -100.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 FY | - CAD | -100.0% |
| 2018 Q4 | 102.49 Thousand CAD | -44.85% |
| 2018 Q3 | 185.85 Thousand CAD | -16.69% |
| 2018 Q2 | 223.09 Thousand CAD | -15.96% |
| 2018 Q1 | 265.47 Thousand CAD | 25.68% |
| 2018 FY | 102.49 Thousand CAD | -51.47% |
| 2017 Q4 | 211.22 Thousand CAD | -58.87% |
| 2017 FY | 211.22 Thousand CAD | -80.0% |
| 2017 Q3 | 513.55 Thousand CAD | -7.56% |
| 2017 Q2 | 555.52 Thousand CAD | -20.48% |
| 2017 Q1 | 698.56 Thousand CAD | -33.87% |
| 2016 FY | 1.05 Million CAD | 196.47% |
| 2016 Q3 | 1.38 Million CAD | 4.39% |
| 2016 Q2 | 1.32 Million CAD | 11.38% |
| 2016 Q1 | 1.19 Million CAD | 4.47% |
| 2016 Q4 | 1.05 Million CAD | -23.77% |
| 2015 Q4 | 1.14 Million CAD | 46.52% |
| 2015 Q3 | 778.61 Thousand CAD | 118.53% |
| 2015 Q1 | - CAD | -100.0% |
| 2015 Q2 | 356.28 Thousand CAD | 0.0% |
| 2015 FY | 356.28 Thousand CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q4 | 225 Thousand CAD | 0.0% |
| 2014 Q1 | - CAD | 100.0% |
| 2014 FY | 356.28 Thousand CAD | 2233.34% |
| 2014 Q3 | - CAD | 0.0% |
| 2013 FY | -16.7 Thousand CAD | -283.99% |
| 2013 Q4 | -7493.00 CAD | -268.75% |
| 2013 Q3 | -2032.00 CAD | 82.63% |
| 2013 Q2 | -11.69 Thousand CAD | 18.24% |
| 2013 Q1 | -14.3 Thousand CAD | 0.0% |
| 2012 Q3 | - CAD | -100.0% |
| 2012 Q1 | 56.25 Thousand CAD | 0.0% |
| 2012 Q2 | 9077.00 CAD | -83.86% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 FY | 9077.00 CAD | -90.44% |
| 2011 FY | 94.92 Thousand CAD | -84.01% |
| 2011 Q4 | 56.25 Thousand CAD | -28.83% |
| 2011 Q3 | 79.04 Thousand CAD | -16.73% |
| 2011 Q1 | 546.03 Thousand CAD | -2.13% |
| 2011 Q2 | 94.92 Thousand CAD | -82.61% |
| 2010 Q3 | 552.29 Thousand CAD | -6.95% |
| 2010 Q4 | 557.9 Thousand CAD | 1.02% |
| 2010 Q1 | 669.26 Thousand CAD | 23.71% |
| 2010 FY | 593.57 Thousand CAD | 859.95% |
| 2010 Q2 | 593.57 Thousand CAD | -11.31% |
| 2009 Q1 | 47.51 Thousand CAD | -12.51% |
| 2009 FY | 61.83 Thousand CAD | 492.11% |
| 2009 Q2 | 61.83 Thousand CAD | 30.15% |
| 2009 Q4 | 541 Thousand CAD | 0.0% |
| 2008 Q4 | 54.3 Thousand CAD | 222.86% |
| 2008 Q1 | 11.85 Thousand CAD | -21.63% |
| 2008 Q3 | 16.81 Thousand CAD | 61.06% |
| 2008 FY | 10.44 Thousand CAD | -47.56% |
| 2008 Q2 | 10.44 Thousand CAD | -11.9% |
| 2007 Q4 | 15.12 Thousand CAD | -9.86% |
| 2007 Q1 | 22.01 Thousand CAD | -13.01% |
| 2007 Q2 | 19.91 Thousand CAD | -9.51% |
| 2007 Q3 | 16.78 Thousand CAD | -15.75% |
| 2007 FY | 19.91 Thousand CAD | -36.33% |
| 2006 Q3 | 25.11 Thousand CAD | -19.72% |
| 2006 Q4 | 25.3 Thousand CAD | 0.76% |
| 2006 Q2 | 31.28 Thousand CAD | -0.28% |
| 2006 Q1 | 31.36 Thousand CAD | 2.33% |
| 2006 FY | 31.28 Thousand CAD | -28.37% |
| 2005 Q2 | 43.66 Thousand CAD | -34.55% |
| 2005 Q3 | 38.46 Thousand CAD | -11.91% |
| 2005 FY | 43.66 Thousand CAD | -69.87% |
| 2005 Q4 | 30.65 Thousand CAD | -20.31% |
| 2005 Q1 | 66.72 Thousand CAD | -14.64% |
| 2004 Q1 | 180.1 Thousand CAD | -6.03% |
| 2004 FY | 144.91 Thousand CAD | 0.0% |
| 2004 Q3 | 110.74 Thousand CAD | -23.58% |
| 2004 Q4 | 78.16 Thousand CAD | -29.42% |
| 2004 Q2 | 144.91 Thousand CAD | -19.54% |
| 2003 Q3 | - CAD | 0.0% |
| 2003 Q2 | - CAD | 0.0% |
| 2003 FY | - CAD | 0.0% |
| 2003 Q4 | 191.66 Thousand CAD | 0.0% |
| 2003 Q1 | - CAD | 0.0% |
| 2002 FY | - CAD | 0.0% |
| 2002 Q3 | - CAD | 0.0% |
| 2002 Q4 | - CAD | 0.0% |
| 2001 FY | - CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Bio Medica Corporation | 379 Thousand USD | 94.545% |
| Arrayit Corporation | 464.19 Thousand USD | 95.546% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 757 Thousand USD | 97.269% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | -2385.00 USD | 966.918% |
| DermTech, Inc. | 1 Million USD | 97.941% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | 99.373% |
| HTG Molecular Diagnostics, Inc. | 909.32 Thousand USD | 97.726% |
| iMD Companies, Inc. | 38.31 Thousand USD | 46.038% |
| IDenta Corp. | 442.28 Thousand USD | 95.325% |
| Interpace Biosciences, Inc. | 1.22 Million USD | 98.315% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 163.13 Thousand USD | 87.326% |
| Lumos Diagnostics Holdings Limited | 784 Thousand USD | 97.363% |
| Many Bright Ideas Technologies Inc. | -375.00 USD | 5613.6% |
| Medical Imaging Corp. | - USD | -Infinity% |
| NovelStem International Corp. | - USD | -Infinity% |
| Optigenex Inc. | 468.77 Thousand USD | 95.589% |
| PharmChem, Inc. | 391.93 Thousand USD | 94.725% |
| Proteome Sciences plc | 1.06 Million USD | 98.06% |
| Response Genetics, Inc | 133 Thousand USD | 84.454% |
| Rennova Health, Inc. | 242.64 Thousand USD | 91.479% |
| RushNet, Inc. | - USD | -Infinity% |
| ScreenPro Security Inc. | 73.89 Thousand USD | 72.021% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 95.62 Thousand USD | 78.377% |
| Todos Medical Ltd. | 1.02 Million USD | 97.975% |